[Skip to Navigation]
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
JAMA Network Home
JAMA
Sign In
New Online Current Issue Past Issues
JAMA Network Statement on Potentially Offensive Content

January 2023 - July 1883

Decade

Year

Issue

June 8, 2011, Vol 305, No. 22, Pages 2257-2368 | Cancer

Preliminary Communication

KIT as a Therapeutic Target in Metastatic Melanoma

Richard D. Carvajal, MD; Cristina R. Antonescu, MD; Jedd D. Wolchok, MD, PhD; et al.
Abstract Full Text
free access
JAMA. 2011;305(22):2327-2334. doi:10.1001/jama.2011.746
This Week in JAMA

This Week in JAMA

Abstract Full Text
free access has audio
JAMA. 2011;305(22):2257. doi:10.1001/jama.2011.782
A Piece of My Mind

Way Back When

Katherine E. Reeder-Hayes, MD, MBA
Abstract Full Text
JAMA. 2011;305(22):2266-2267. doi:10.1001/jama.2011.419
Original Contribution

Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial

Saundra S. Buys, MD; Edward Partridge, MD; Amanda Black, PhD, MPH; et al.
Abstract Full Text
free access
JAMA. 2011;305(22):2295-2303. doi:10.1001/jama.2011.766

Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome

Valérie Bonadona, MD, PhD; Bernard Bonaïti, MSc; Sylviane Olschwang, MD, PhD; et al.
Abstract Full Text
free access
JAMA. 2011;305(22):2304-2310. doi:10.1001/jama.2011.743

Long-term Risks of Subsequent Primary Neoplasms Among Survivors of Childhood Cancer

Raoul C. Reulen, PhD; Clare Frobisher, PhD; David L. Winter; et al.
Abstract Full Text
free access
JAMA. 2011;305(22):2311-2319. doi:10.1001/jama.2011.747

Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer

Aaron S. Kesselheim, MD, JD, MPH; Jessica A. Myers, PhD; Jerry Avorn, MD
Abstract Full Text
free access
JAMA. 2011;305(22):2320-2326. doi:10.1001/jama.2011.769
Editorial

Cancer Risk Assessment in Lynch Syndrome: Does the Gene Matter?

Rosa M. Xicola, PhD; Xavier Llor, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2351-2352. doi:10.1001/jama.2011.771
Review

Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer: A Systematic Review and Meta-analysis

James J. Biagi, MD; Michael J. Raphael; William J. Mackillop, MB, ChB; et al.
Abstract Full Text
JAMA. 2011;305(22):2335-2342. doi:10.1001/jama.2011.749
Medical News & Perspectives

Debate Continues on Use of PSA Testing for Early Detection of Prostate Cancer

M. J. Friedrich
Abstract Full Text
JAMA. 2011;305(22):2273-2276. doi:10.1001/jama.2011.777

Retinoblastoma Therapy Delivers Power of Chemotherapy With Surgical Precision

M. J. Friedrich
Abstract Full Text
JAMA. 2011;305(22):2276-2278. doi:10.1001/jama.2011.778

Studies Probe Role of Telomere Length in Predicting, Modulating Cancer Risk

Tracy Hampton, PhD
Abstract Full Text
JAMA. 2011;305(22):2278-2279. doi:10.1001/jama.2011.772
News From the Centers for Disease Control and Prevention

Cancer Survivors—United States, 2007

Abstract Full Text
free access
JAMA. 2011;305(22):2281-2282. doi:

Bullying Among Middle School and High School Students—Massachusetts, 2009

Abstract Full Text
free access
JAMA. 2011;305(22):2283-2286. doi:
Capitol Health Call

VA Oversight Questioned

Mike Mitka
Abstract Full Text
JAMA. 2011;305(22):2280. doi:10.1001/jama.2011.773

Measuring Countermeasures

Mike Mitka
Abstract Full Text
JAMA. 2011;305(22):2280. doi:10.1001/jama.2011.774

Quality Improvement

Mike Mitka
Abstract Full Text
JAMA. 2011;305(22):2280. doi:10.1001/jama.2011.775

Device Approval

Mike Mitka
Abstract Full Text
JAMA. 2011;305(22):2280. doi:10.1001/jama.2011.776
Letters

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

Ismail Jatoi, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.750

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

I-Chun Chen, MD; Ching-Hung Lin, MD; Yen-Shen Lu, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.751

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

Michael D. Hasselle, MD; Paige L. Dorn, MD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.752

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

Merdan Fayda, MD; Ronald Chen, MD, MPH
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.753

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

Benjamin O. Anderson, MD; Julie R. Gralow, MD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.754

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

Seenu Vuthaluru, MS; Anurag Srivastava, MS, FRCS, MPhil, PhD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.755

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer—Reply

Armando E. Giuliano, MD; Monica Morrow, MD; Karla V. Ballman, PhD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.756

Bevacizumab and Cancer Treatment-Related Mortality

Zu-Yao Yang, MD; Chen Mao, MD; Jin-Ling Tang, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2291-2293. doi:10.1001/jama.2011.757

Bevacizumab and Cancer Treatment-Related Mortality

Cornelis J. A. Punt, MD, PhD; Linda Mol, MSc; Miriam Koopman, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2291-2293. doi:10.1001/jama.2011.758

Bevacizumab and Cancer Treatment-Related Mortality

Patricia B. Cerrito, PhD
Abstract Full Text
JAMA. 2011;305(22):2291-2293. doi:10.1001/jama.2011.759

Bevacizumab and Cancer Treatment-Related Mortality—Reply

Shenhong Wu, MD, PhD; Vishal Ranpura, MD; Sanjay Hapani, MD
Abstract Full Text
JAMA. 2011;305(22):2291-2293. doi:10.1001/jama.2011.760

Antibiotic Resistance and the Future

Kanika Deshpande Koirala, MBBS; Sudeep Dhoj Thapa, MBBS
Abstract Full Text
JAMA. 2011;305(22):2293-2294. doi:10.1001/jama.2011.761

Antibiotic Resistance and the Future—Reply

James M. Hughes, MD
Abstract Full Text
JAMA. 2011;305(22):2293-2294. doi:10.1001/jama.2011.762
The Cover

Penumbra

Thomas B. Cole, MD, MPH
Abstract Full Text
JAMA. 2011;305(22):2261. doi:10.1001/jama.2011.770
Poetry and Medicine

For Harriet

Richard Schiffman
Abstract Full Text
JAMA. 2011;305(22):2263. doi:10.1001/jama.2011.654
JAMA Patient Page

Melanoma

Ryszard M. Pluta, MD, PhD; Alison E. Burke, MA; Robert M. Golub, MD
Abstract Full Text
free access
JAMA. 2011;305(22):2368. doi:10.1001/jama.2011.658
Correction

Error in Data Extraction and Analyses in: Treatment-Related Mortality With Bevacizumab in Cancer Patients: A Meta-analysis

Abstract Full Text
free access
JAMA. 2011;305(22):2294. doi:10.1001/jama.2011.763
JAMA Masthead

About This Journal

Abstract Full Text
free access
JAMA. 2011;305(22):2259-2260. doi:10.1001/jama.305.22.2259
Commentary

A Strategic Approach to Therapeutic Cancer Vaccines in the 21st Century

Matthew M. Davis, MD, MAPP; Elias J. Dayoub, BA
Abstract Full Text
JAMA. 2011;305(22):2343-2344. doi:10.1001/jama.2011.814

Balancing Access and Evaluation in the Approval of New Cancer Drugs

Franklin G. Miller, PhD; Steven Joffe, MD, MPH
Abstract Full Text
JAMA. 2011;305(22):2345-2346. doi:10.1001/jama.2011.784

Realigning Incentives for Developing and Pricing New Anticancer Treatments

David H. Howard, PhD
Abstract Full Text
JAMA. 2011;305(22):2347-2348. doi:10.1001/jama.2011.793

Seeing the Future of Cancer-Associated Transcription Factor Drug Targets

Panagiotis A. Konstantinopoulos, MD, PhD; Athanasios G. Papavassiliou, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2349-2350. doi:10.1001/jama.2011.727
JAMA 100 Years Ago

A Preliminary Report on the Mortality of Cancer in the United States, as Given by the Census of 1910

Abstract Full Text
JAMA. 2011;305(22):2359. doi:10.1001/jama.2011.737
Book and Media Reviews

Cancer Genetics

Charis Eng, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2353. doi:10.1001/jama.2011.794

Adult Acute Lymphocytic Leukemia: Biology and Treatment

Paulette Mehta, MD, MPH
Abstract Full Text
JAMA. 2011;305(22):2353-2358. doi:10.1001/jama.2011.795

From Dark Night to Gentle Surrender: On the Ethics and Spirituality of Hospice Care

Michael D. Barnett, MD
Abstract Full Text
JAMA. 2011;305(22):2353-2358. doi:10.1001/jama.2011.796

Hope in the Age of Anxiety

Elaine C. Meyer, PhD, RN
Abstract Full Text
JAMA. 2011;305(22):2353-2358. doi:10.1001/jama.2011.797

The Emperor of All Maladies: A Biography of Cancer

Paulette Mehta, MD, MPH
Abstract Full Text
JAMA. 2011;305(22):2357-2358. doi:10.1001/jama.2011.798

Latest from the USPSTF

View more >
Most Viewed(30 Days) RSS link
Most Cited(3 Years) RSS Link
View more
View more
×
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
  • Register for email alerts with links to free full-text articles
  • Access PDFs of free articles
  • Manage your interests
  • Save searches and receive search alerts
Privacy Policy